Form 4: 89bio, Inc. Executive Sells Shares Under 10b5-1 Trading Plan

Quoc Le-Nguyen, Chief Technical Operations Officer of 89bio, Inc., sold 27,955 shares of common stock at an average price of $8.12 per share under a pre-arranged 10b5-1 trading plan.

Summary

• On October 30, 2024, Quoc Le-Nguyen, the Chief Technical Operations Officer of 89bio, Inc. (ETNB), sold 27,955 shares of the company's common stock.
• The sale was executed under a Rule 10b5-1 trading plan adopted on July 1, 2024.
• The shares were sold at a weighted average price of $8.12, with individual transactions ranging from $8.00 to $8.25 per share.
• Following the transaction, Le-Nguyen directly owns 187,796 shares of 89bio, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates